Please see below for a list of search results.
The HTA has published its annual Business Plan for 2017/18 and a refreshed version of our three-year Strategy.
Last summer, the Health Research Authority (HRA) and the Human Tissue Authority (HTA) - in partnership with the Department for Business, Enterprise, Innovation and Skills’ (BEIS) Sciencewise programme and Ipsos MORI - published the report ‘
All establishments licensed under the Human Tissue Act 2004 and the Quality and Safety of Organs Intended for Transplantation Regulations 2012 must review their licensing records and complete a compliance update.
The information collected will be used to:
In line with the HTA’s commitment to increase transparency, we publish details about the volume and nature of incidents that are reported to us. This includes HTA Reportable Incidents (HTARIs) in the Post Mortem sector and Serious Adverse Events and Reactions in the Human Application and Organ...